For the next seven years, researchers at Arkansas Children’s Hospital will continue to host therapeutic trials and study food allergies thanks to new money allocated by the NIH. The $2.3 million allocated will be for studying allegies of tree nuts, milk, eggs, peanuts, wheat and other foods. The money will go to the Arkansas Center for Food Allergy Research, which has been in operation for over 20 years. Earlier this year, research conducted by the center led to the first FDA approved biologic treatment for children and adults with allergies to peanuts and other foods. This next phase of funding will help the ACFAR create better opportunities for global implementation of the most effective therapeutic and prevention options.